Additionally, a combined SK2/cisplatin treatment shows synergistic inductions of annexin V, pancaspase, Cas 3/8/9, and Cas 3/7 (Figure 3 and Figure 4) in oral cancer cells but not in normal oral cells. Here, ANXA5 is linked to lip and oral cavity carcinoma.